Evidence map›Paper›PMID 18427908›Full record

ArticleInternational journal of hematology2008

Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion.

Michihide Tokuhira, Atsushi Iizuka, Reiko Watanabe, Naoya Sekiguchi, Norihide Sato, Chen-Kang Chien, Yasunobu Sekiguchi, Tomoe Nemoto, Kyoko Hanzawa, Jun-Ichi Tamaru and 5 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Michihide TokuhiraDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan. tokuhira@saitama-med.ac.jp.
Atsushi IizukaDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Reiko WatanabeDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Naoya SekiguchiDivision of Rheumatology, Department of Internal Medicine, Saitama Medical Center, Kawagoe, Saitama, Japan.
Norihide SatoDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Chen-Kang ChienDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Yasunobu SekiguchiDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Tomoe NemotoDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Kyoko HanzawaDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Jun-Ichi TamaruDepartment of Pathology, Saitama Medical Center, Kawagoe, Saitama, Japan.
Shinji ItoyamaDepartment of Pathology, Saitama Medical Center, Kawagoe, Saitama, Japan.
Hiroshi SuzukiTransfusion Center, National Defense Medical College, Tokorozawa, Saitama, Japan.
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Saitama Medical Center, Kawagoe, Saitama, Japan.
Shigehisa MoriDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Masahiro KizakiDivision of Hematology, Department of Internal Medicine, Saitama Medical Center, 1981 Kamodatsujido, Kawagoe, Saitama, 350-8550, Japan.
Social Insurance Saitama Chuo Hospital · JPSaitama Medical University · JPNational Defense Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We here report the case of a young Japanese woman diagnosed with chronic active Epstein-Barr virus (EBV) infection. Intensive therapy with the CHOP regimen was partially able to control virus expansion, but various central nervous system symptoms appeared and gradually progressed. EBV-encoded RNA, detected using in situ hybridization, disclosed the presence of EBV in liver and bone marrow tissue, and real-time PCR revealed the presence of EBV in the cerebrospinal fluid (CSF) and serum. CD3+CD4+CD8-CD56- T-cell expansion in the peripheral blood (PB) and CSF was also observed. Atrophic brain changes were progressive, and the patient died of central nervous system disturbance and pulmonary hemorrhage a year after diagnosis. Autopsy revealed that EBV-infected T lymphocytes with a phenotype similar to those seen in PB and CSF had infiltrated multiple organs: the lymph nodes, bone marrow, endocardium, pericardium, myocardium, spleen, liver, and spinal cord. There have been few previous reports of severe degenerative changes in the myocardium, liver, and spinal cord in patients with EBV infection. Although EBV occasionally infiltrates the central nervous system and brain, atrophic changes mediated by EBV are rare. The autopsy results of this case suggest the possibility of EBV-mediated, severe degenerative changes in multiple organs.

Indexed as

Herpesvirus 4, HumanAdultAntineoplastic Combined Chemotherapy ProtocolsAutopsyCD4-Positive T-LymphocytesCyclophosphamideDoxorubicinEpstein-Barr Virus InfectionsFemaleHumansImmunohistochemistryLiverMyocardiumPrednisoneRNA, ViralSpinal CordCyclophosphamideDoxorubicinPrednisoneRNA, ViralVincristine

Identifiers

PMID18427908
OpenAlexW2110242454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.